(Q34886836)

English

Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma

scientific article

Statements

Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma (English)
0 references
0 references
MD Anderson Community Clinical Oncology Program
Brain Tumor Trials Collaborative

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit